**Core Concept**
The question tests the understanding of **mydriasis** and **cycloplegia** in the context of ophthalmological examinations, specifically the use of **anticholinergic** and **adrenergic** agents. Atropine is an **antimuscarinic** agent that induces both mydriasis and cycloplegia.

**Why the Correct Answer is Right**
Atropine is substituted by phenylephrine when the goal is to achieve mydriasis without cycloplegia, as phenylephrine is a **pure alpha-adrenergic agonist** that causes pupil dilation without affecting accommodation. This is particularly useful in situations where preserving the patient's ability to focus is necessary.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a condition where atropine's cycloplegic effect is undesirable.
**Option B:** Incorrect because it does not relate to the specific context of mydriasis versus cycloplegia.
**Option C:** Incorrect as it does not address the need for preserving accommodation during the examination.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **phenylephrine** can be used for mydriasis without cycloplegia, making it useful for fundus examinations where the patient's ability to accommodate should be preserved.

**Correct Answer:** D. In children to avoid the risk of psychotropic and behavioral side effects associated with atropine.